Press release
Allergy Immunotherapy Market Scope and Profit-Sources Detailed Analysis
Allergy Immunotherapy Market is to reach over USD 4.01 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Region, Market Outlook And Industry Analysis 2031"
The global Allergy Immunotherapy market is estimated to reach over USD 4.01 billion by 2031, exhibiting a CAGR of 8.7% during the forecast period.
Get Free Sample Copy of Report : https://www.insightaceanalytic.com/request-sample/1924
The predicted increase in income might be related to the burden of allergy illnesses, which is becoming more prevalent globally. The burden that complex allergies with increased morbidity place on the healthcare system motivate R&D in this area and the introduction of novel medicines. In addition, the prevalence of asthma and allergy respiratory illnesses has increased as a result of rising air pollution levels both inside and outside. According to the Asthma and Allergy Foundation of America (AAFA), rising pollen levels are the root cause of more than 25 million allergies.
According to the Canadian Allergy, Asthma, and Immunology Foundation, between 20 and 25 percent of Canadians suffer from allergic rhinitis. Additionally, traditional symptomatic drugs are ineffective in treating 50% of the affected individuals. As a result, major corporations are concentrating on creating novel immunotherapy medicines. As an illustration, in 2019 ALK made a filing to the Canadian regulatory agency for its experimental tree SLIT-tablet.
List of Prominent Players in the Allergy Immunotherapy Market:
• ASIT Biotech
• Circassia
• Mylan N.V.
• Adamis Pharmaceuticals Corporation
• Merck KGaA
• Stallergenes Greer plc
• Allergy Therapeutics
• ALK-Abelló A/S
• DESENTUM OY
• HAL Allergy B.V.
• HollisterStier Allergy
• LETIPharma
• DBV Technologies SA
Market Dynamics:
Drivers-
The global market for allergy immunotherapy is anticipated to expand as a result of the increasing incidence and prevalence of allergic illnesses. For instance, the Centres for Disease Control and Prevention reported that in 2018, there were 19.2 million cases of hay fever in adults over the age of 18 and 5.2 million cases in children under the age of 18. Additionally, rising pollution and environmental changes are fueling the expansion of the global market for allergy immunotherapy. For instance, the Asthma and Allergy Foundation of America (AAFA) estimates that over 23 million Americans suffer from symptoms of ragweed pollen allergy. For those who have allergies, these symptoms can make life miserable. They can also create asthma symptoms worse for those who have allergies and asthma.
Challenges:
Despite the many advantages of allergy immunotherapy, there is a poor rate of population compliance due to several issues, including inadequate patient knowledge and a lack of adequate funding. For instance, a 2022 article in the NCBI claims that the inconvenience of SCIT and the negative effects of subcutaneous and sublingual therapy are the main causes of patients stopping these treatments. Additionally, the cost of allergy shots in the United States ranges from USD 1,600 to USD 4,000 annually for those without insurance coverage to USD 800 annually for those who receive sufficient reimbursement. Additionally, the SLIT drops in the nation have not yet received approval and are not insured. Hence, the high price for the therapy is limiting the market's expansion.
Regional Trends:
The region with the fastest CAGR was Europe, which is anticipated to maintain its lead throughout the projected period. This is explained by the substantial participation of key market players like ASIT Biotech, Circassia, Mylan N.V., and Merck KGaA. More than 150 million people in Europe currently have allergic illnesses, and by 2025, it is predicted that more than 50% of the region's population would have at least one type of allergy as a result of several factors, including industrialization, urbanization, climate change, and pollution.
Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/1924
Recent Developments:
• In July 2022, The good findings regarding the significant advantage of sublingual liquid allergen immunotherapy treatment (AIT) on the beginning and worsening of asthma in patients with allergic rhinitis was released by Stallergenes Greer, a worldwide healthcare firm that specializes in allergen immunotherapy (AIT).
Segmentation of Allergy Immunotherapy Market-
By Treatment Type-
• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)
• Tablets
• Drops
By Allergy Type-
• Allergic rhinitis
• Allergic asthma
• Others
By Distribution Channel-
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/report/allergy-immunotherapy-market-/1924
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Region, Market Outlook And Industry Analysis 2031"
The global Allergy Immunotherapy market is estimated to reach over USD 4.01 billion by 2031, exhibiting a CAGR of 8.7% during the forecast period.
Get Free Sample Copy of Report : https://www.insightaceanalytic.com/request-sample/1924
The predicted increase in income might be related to the burden of allergy illnesses, which is becoming more prevalent globally. The burden that complex allergies with increased morbidity place on the healthcare system motivate R&D in this area and the introduction of novel medicines. In addition, the prevalence of asthma and allergy respiratory illnesses has increased as a result of rising air pollution levels both inside and outside. According to the Asthma and Allergy Foundation of America (AAFA), rising pollen levels are the root cause of more than 25 million allergies.
According to the Canadian Allergy, Asthma, and Immunology Foundation, between 20 and 25 percent of Canadians suffer from allergic rhinitis. Additionally, traditional symptomatic drugs are ineffective in treating 50% of the affected individuals. As a result, major corporations are concentrating on creating novel immunotherapy medicines. As an illustration, in 2019 ALK made a filing to the Canadian regulatory agency for its experimental tree SLIT-tablet.
List of Prominent Players in the Allergy Immunotherapy Market:
• ASIT Biotech
• Circassia
• Mylan N.V.
• Adamis Pharmaceuticals Corporation
• Merck KGaA
• Stallergenes Greer plc
• Allergy Therapeutics
• ALK-Abelló A/S
• DESENTUM OY
• HAL Allergy B.V.
• HollisterStier Allergy
• LETIPharma
• DBV Technologies SA
Market Dynamics:
Drivers-
The global market for allergy immunotherapy is anticipated to expand as a result of the increasing incidence and prevalence of allergic illnesses. For instance, the Centres for Disease Control and Prevention reported that in 2018, there were 19.2 million cases of hay fever in adults over the age of 18 and 5.2 million cases in children under the age of 18. Additionally, rising pollution and environmental changes are fueling the expansion of the global market for allergy immunotherapy. For instance, the Asthma and Allergy Foundation of America (AAFA) estimates that over 23 million Americans suffer from symptoms of ragweed pollen allergy. For those who have allergies, these symptoms can make life miserable. They can also create asthma symptoms worse for those who have allergies and asthma.
Challenges:
Despite the many advantages of allergy immunotherapy, there is a poor rate of population compliance due to several issues, including inadequate patient knowledge and a lack of adequate funding. For instance, a 2022 article in the NCBI claims that the inconvenience of SCIT and the negative effects of subcutaneous and sublingual therapy are the main causes of patients stopping these treatments. Additionally, the cost of allergy shots in the United States ranges from USD 1,600 to USD 4,000 annually for those without insurance coverage to USD 800 annually for those who receive sufficient reimbursement. Additionally, the SLIT drops in the nation have not yet received approval and are not insured. Hence, the high price for the therapy is limiting the market's expansion.
Regional Trends:
The region with the fastest CAGR was Europe, which is anticipated to maintain its lead throughout the projected period. This is explained by the substantial participation of key market players like ASIT Biotech, Circassia, Mylan N.V., and Merck KGaA. More than 150 million people in Europe currently have allergic illnesses, and by 2025, it is predicted that more than 50% of the region's population would have at least one type of allergy as a result of several factors, including industrialization, urbanization, climate change, and pollution.
Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/1924
Recent Developments:
• In July 2022, The good findings regarding the significant advantage of sublingual liquid allergen immunotherapy treatment (AIT) on the beginning and worsening of asthma in patients with allergic rhinitis was released by Stallergenes Greer, a worldwide healthcare firm that specializes in allergen immunotherapy (AIT).
Segmentation of Allergy Immunotherapy Market-
By Treatment Type-
• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)
• Tablets
• Drops
By Allergy Type-
• Allergic rhinitis
• Allergic asthma
• Others
By Distribution Channel-
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/report/allergy-immunotherapy-market-/1924
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
